These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 1582018)
21. Reversed-phase liquid chromatographic investigation of nucleosides and bases in mucosa and modified nucleosides in urines from patients with gastrointestinal cancer. Nakano K; Shindo K; Yasaka T; Yamamoto H J Chromatogr; 1985 Sep; 332():127-37. PubMed ID: 4055938 [TBL] [Abstract][Full Text] [Related]
22. Succinic acid enhanced quantitative determination of blood modified nucleosides in the development of diabetic nephropathy based on hydrophilic interaction liquid chromatography mass spectrometry. Guo M; Liu D; Sha Q; Geng H; Liang J; Tang D J Pharm Biomed Anal; 2019 Feb; 164():309-316. PubMed ID: 30412804 [TBL] [Abstract][Full Text] [Related]
23. The urinary excretion of nucleosides of ribonucleic acid by patients with advanced cancer. Waalkes TP; Gehrke CW; Zumwalt RW; Chang SY; Lakings DB; Tormey DC; Ahmann DL; Moertel CG Cancer; 1975 Aug; 36(2):390-8. PubMed ID: 1157009 [TBL] [Abstract][Full Text] [Related]
24. Determination of pseudouridine and other nucleosides in human blood serum by high-performance liquid chromatography. Colonna A; Russo T; Esposito F; Salvatore F; Cimino F Anal Biochem; 1983 Apr; 130(1):19-26. PubMed ID: 6869800 [TBL] [Abstract][Full Text] [Related]
25. Higher detectability method for the analysis of nucleosides, putative tumor biomarkers, in blood serum samples by CE-UV with reversed EOF. Buzatto AZ; Guedes SF; de Oliveira Silva M; Gallafrio JM; Simionato AV Electrophoresis; 2015 Dec; 36(23):2968-75. PubMed ID: 26250155 [TBL] [Abstract][Full Text] [Related]
26. [Serum 1-methyladenosine and pseudouridine as tumor markers in tumor-bearing mice]. Ishiwata S; Itoh K; Yamaguchi T; Sasaki S; Ishida N; Mizugaki M Yakugaku Zasshi; 1995 Jul; 115(7):523-7. PubMed ID: 7562399 [TBL] [Abstract][Full Text] [Related]
27. Urinary excretion of modified nucleosides as biological marker of RNA turnover in patients with cancer and AIDS. Nakano K; Nakao T; Schram KH; Hammargren WM; McClure TD; Katz M; Petersen E Clin Chim Acta; 1993 Sep; 218(2):169-83. PubMed ID: 7508341 [TBL] [Abstract][Full Text] [Related]
28. Analysis of modified nucleosides in the urine of patients with malignant cancer by liquid chromatography/electrospray ionization mass spectrometry. Li HY; Wang SM; Liu HM; Li J; Han D; Bu SS; Zhang MZ Rapid Commun Mass Spectrom; 2008 Oct; 22(20):3161-71. PubMed ID: 18798199 [TBL] [Abstract][Full Text] [Related]
29. [Application of urinary nucleosides in the diagnosis and surgical monitoring of colorectal cancer]. Feng B; Zheng MH; Zheng YF; Lu AG; Li JW; Wang ML; Ma JJ; Xu GW; Yu BM Zhonghua Wai Ke Za Zhi; 2005 May; 43(9):564-8. PubMed ID: 15938925 [TBL] [Abstract][Full Text] [Related]
30. RNA metabolism in uremic patients: accumulation of modified ribonucleosides in uremic serum. Technical note. Niwa T; Takeda N; Yoshizumi H Kidney Int; 1998 Jun; 53(6):1801-6. PubMed ID: 9607216 [TBL] [Abstract][Full Text] [Related]
31. Serum levels of N2, N2-dimethylguanosine and pseudouridine as determined by radioimmunoassay for patients with malignancy. Levine L; Waalkes TP; Stolbach L J Natl Cancer Inst; 1975 Feb; 54(2):341-3. PubMed ID: 1117461 [TBL] [Abstract][Full Text] [Related]
32. A new way to fast and high resolution determination of modified nucleosides. Studzińska S; Buszewski B J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Mar; 887-888():93-101. PubMed ID: 22309775 [TBL] [Abstract][Full Text] [Related]
33. Age-dependence of urinary normal and modified nucleosides in childhood as determined by reversed-phase high-performance liquid chromatography. Liebich HM; Müller-Hagedorn S; Bacher M; Scheel-Walter HG; Lu X; Frickenschmidt A; Kammerer B; Kim KR; Gérard H J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jan; 814(2):275-83. PubMed ID: 15639449 [TBL] [Abstract][Full Text] [Related]
34. Direct clean-up and analysis of ribonucleosides in physiological fluids. Schlimme E; Boos KS; Hagemeier E; Kemper K; Meyer U; Hobler H; Schnelle T; Weise M J Chromatogr; 1986 Jun; 378(2):349-60. PubMed ID: 3733993 [TBL] [Abstract][Full Text] [Related]
35. Pyrimidine nucleoside, pseudouridine, and modified nucleoside excretion by growing and resting fibroblasts. Uziel M; Selkirk JK J Cell Physiol; 1979 May; 99(2):217-22. PubMed ID: 457787 [TBL] [Abstract][Full Text] [Related]
36. Urinary excretion by cancer patients of the nucleosides N-dimethylguanosine, 1-methylinosine, and pseudouridine. Waalkes TP; Dinsmore SR; Mrochek JE J Natl Cancer Inst; 1973 Jul; 51(1):271-4. PubMed ID: 4720877 [No Abstract] [Full Text] [Related]
37. Possible use of urinary modified RNA metabolites in the measurement of RNA turnover in the human body. Sander G; Topp H; Wieland J; Heller-Schöch G; Schöch G Hum Nutr Clin Nutr; 1986 Mar; 40(2):103-18. PubMed ID: 2420752 [TBL] [Abstract][Full Text] [Related]
38. Modified nucleosides as biomarkers for early cancer diagnose in exposed populations. Seidel A; Seidel P; Manuwald O; Herbarth O Environ Toxicol; 2015 Jul; 30(8):956-67. PubMed ID: 24615900 [TBL] [Abstract][Full Text] [Related]
39. Liquid chromatography tandem mass spectrometry study of urinary nucleosides as potential cancer markers. Struck W; Siluk D; Yumba-Mpanga A; Markuszewski M; Kaliszan R; Markuszewski MJ J Chromatogr A; 2013 Mar; 1283():122-31. PubMed ID: 23465127 [TBL] [Abstract][Full Text] [Related]
40. Urinary excretion of six modified nucleosides by patients with breast carcinoma. Vreken P; Tavenier P Ann Clin Biochem; 1987 Nov; 24 ( Pt 6)():598-603. PubMed ID: 3426126 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]